Table 2.
Intervention and outcomes by sex (N = 334)
| Variable | P value | Total N = 334 |
Female N = 60 |
Male N = 274 |
|---|---|---|---|---|
| Days from admit to 1st operation | 0.42 | 3 (1–5) | 3 (1–7) | 3 (1–5) |
| Operation total | 0.66 | 3 (1–6) | 2 (16) | 3 (1–16) |
| Postoperative complication | 0.76 | 133 (40%) | 22 (37%) | 111 (41%) |
| Requiring autograft | 0.08 | 241 (72%) | 38 (63%) | 203 (74%) |
| Autograft complication | 1.00 | 53 (16%) | 8 (13%) | 45 (16%) |
| Requiring homograft | 0.28 | 62 (19%) | 8 (13%) | 54 (20%) |
| Homograft complication | <0.05 | 23 (7%) | 6 (10%) | 17 (6%) |
| Integra | 0.53 | 43 (13%) | 6 (10%) | 37 (14%) |
| Integra complication | 0.66 | 16 (5%) | 3 (5%) | 13 (5%) |
| Patients requiring intubation | 0.86 | 258 (77%) | 47 (78%) | 211 (77%) |
| Ventilator days | 0.73 | 3 (1–14) | 3 (1–11) | 3 (1–15) |
| Length of stay | 0.61 | 28 (18–45) | 27 (18–48) | 28 (18–43) |
| Length of stay per TBSAa | 0.40 | 0.89 (0.67–1.33) | 0.991 (0.68–1.58) | 0.89 (0.66–1.29) |
| Readmissiona | 0.41 | 65 (19%) | 7 (12%) | 58 (21%) |
| Inpatient mortality | <0.05 | 107 (32%) | 27 (45%) | 80 (29%) |
TBSA total body surface area
Values reported as median (interquartile range) or n (%) unless otherwise stated; P values: comparing sites using Rank-sum test for continuous or chi-squared or Fisher’s exact for nominal or categorical variables
aSurvivors only